Correction of a pathogenic gene mutation in human embryos
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Genome editing has potential for the targeted correction of germline mutations. Here we describe the correction of the heterozygous MYBPC3 mutation in human preimplantation embryos with precise CRISPR-Cas9-based targeting accuracy and high homology-directed repair efficiency by activating an endogenous, germline-specific DNA repair response. Induced double-strand breaks (DSBs) at the mutant paternal allele were predominantly repaired using the homologous wild-type maternal gene instead of a synthetic DNA template. By modulating the cell cycle stage at which the DSB was induced, we were able to avoid mosaicism in cleaving embryos and achieve a high yield of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of off-target mutations. The efficiency, accuracy and safety of the approach presented suggest that it has potential to be used for the correction of heritable mutations in human embryos by complementing preimplantation genetic diagnosis. However, much remains to be considered before clinical applications, including the reproducibility of the technique with other heterozygous mutations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Germline editing has been used for years in animals, including mice, rats, monkeys and many others, and experiments show that it can be done in both nonviable or viable human embryos as well 110-113 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [112]
In the citing paper
“Of the studies that have been conducted, the reported efficiencies of repair with templates in human embryos are very low (5,7,8).”
From Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Orthwein, A. et al. Mitosis inhibits DNA double-strand break repair to guard against telomere fusions. Science 344, 189–193 (2014)”
Cited work 10.1126/science.1248024 · retracted 2025-01-09 · notice 10.1126/science.adv1263 · this paper published 2017-08
Citations
Cites
1 retracted
Mitosis Inhibits DNA Double-Strand Break Repair to Guard Against Telomere Fusions
Orthwein, A., Fradet-Turcotte, A., Noordermeer, S. M., Canny, M. D., Brun, C. M., Strecker, J., Escribano-Diaz, C., & Durocher, D. (2014) · Science · doi:10.1126/science.1248024 · Cited by 319
RetractedA Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Self-citationAntoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 701–800 of 948
Li, Z., Li, C., Xiao, S., & Liang, H. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00715 · Cited by 2
Relationship between genotype and clinical phenotype of hypertrophic cardiomyopathy
Zhang, L., Wang, B., Wang, J., Zhao, J. W., & Liu, L. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i8.107847 · Cited by 1
Chatterjee, G., & Singh, K. K. (2025) · Genetics. · doi:10.5772/intechopen.1012378 · Cited by 2
Ruan, J., Song, Q., Hu, Y., Liu, X., Li, S., Zhu, J., & Yang, L. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1710280 · Cited by 1
Santoro, D. F., Bellucci, M., Marchis, F. D., Nicolia, A., Micheli, M., & Rosellini, D. (2025) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-025-03303-z · Cited by 1
“Large deletions are not rare among NHEJ-derived mutants (Ma et al. 2017; Kosicki et al. 2018; Park et al. 2022).”
Yin, J., Wen, H., Zeng, J., Sun, Y., Chen, X., Jin, L. G., Song, Y., & Xia, S. (2026) · Biology of Reproduction · doi:10.1093/biolre/ioag056 · Cited by 3
Human embryo editing: 10 years of breakthroughs and challenges
Zhou, Y., Xie, D., Ding, C., Wu, W., Cao, T., Liu, Q., Keefe, D. L., 周灿权, & Huang, J. (2026) · Protein & Cell · doi:10.1093/procel/pwag030 · Cited by 1
Jordan stakes its future on science
Maxmen, A. (2017) · Nature · doi:10.1038/548014a · Cited by 1
Precision editing in the human embryo
Aschheim, K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3965 · Cited by 1
Why the way we look at things in reproductive medicine is changing
Albertini, D. F. (2017) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-1077-1 · Cited by 1
“And finally, when discourse reaches the polarizing base upon which new technology like gene editing has imprinted on the practice of human ARTs (not unlike that being experienced in the political landscapes around the world today), the high road better traveled may be to share with our patients and hopeful consumers h…”
BackgroundInfluentialProfiles in Science for Science Librarians: Ruth Hubbard, Scientist and Social Activist
BARR, D. J. (2017) · Science & Technology Libraries · doi:10.1080/0194262x.2017.1395722 · Cited by 1
“This is an especially topical issue today because of the work done by researchers in Oregon to eliminate a life-threatening defective gene in a mouse embryo (Ma et al. 2017).”
BackgroundTurning the corner from observation to intervention in human genetics
Nelson, D. L. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2018.01.004 · Cited by 1
CRISPR – en revolusjon innen genteknologi?
Halsne, R. (2018) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.17.1038
“Her ble CRISPR brukt til å korrigere MYBPC3-mutasjonen som oftest forårsaker kardiomyopati (10).”
BackgroundOMICS technologies in reproductive medicine: assessment of quality of oocytes and embryos
Zhiryaeva, E. A., Валерьевна, К. Е., & Rizvanov, A. A. (2018) · Genes and Cells · doi:10.23868/201805003 · Cited by 2
La comunicación de la edición genética: CRISPR, Entre el optimismo y las falsas expectativas
Montoliu, L. (2019) · Mètode: Revista de difusió de la investigació de la Universitat de Valencia · doi:10.7203/metode.9.11288 · Cited by 2
CRISPR Highlights and Transition of Cas9 into a Genome Editing Tool
Bentin, T. (2018) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012928-00391 · Cited by 1
Human Germline Genome Editing in the Clinical Context: The Case of Disease Prevention
Rubeis, G. (2018) · Technikzukünfte, Wissenschaft und Gesellschaft · doi:10.1007/978-3-658-22660-2_10 · Cited by 2
Gene, genome, and molecular therapeutics
Kumar, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809356-6.00030-7 · Cited by 1
Tiewsiri, K., Manipalviratn, S., Sutheesophon, W., Vanichsetakul, P., Thaijaroen, P., Ketcharoon, P., Bradley, C. K., McArthur, S. J., Krutsawad, W., Marshall, J. T. A., et al. (2020) · BioMed Research International · doi:10.1155/2020/5292090 · Cited by 1
“In the future, correcting pathogenic gene mutations in human embryos [28] and β-thalassemia using base editing in human somatic cells and embryos [29] may offer other valid alternatives.”
BackgroundHerget, T., Charton, J. E., & Hildemann, S. K. (2020) · Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim · doi:10.1007/978-3-662-59052-2_4 · Cited by 2
Комисаренко, С. В., & Романюк, С. И. (2020) · Visnik Nacional noi academii nauk Ukrai ni · doi:10.15407/visn2020.12.031 · Cited by 4
The Changing Face of Biological Research and the Growing Role of Biosecurity
Dunaway, N., & Berger, K. M. (2021) · Advanced sciences and technologies for security applications · doi:10.1007/978-3-030-69464-7_6 · Cited by 2
Genetics of Cardiovascular Disease and Applications of Genetic Testing
Mahdieh, N., Rabbani, B., & Maleki, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-80915-3.00025-9 · Cited by 1
Gene Therapy, Diet and Drug Approaches to Treating Inherited Retinal Disease
Simunovic, M. P., Mack, H. G., Ayton, L. N., & Hassall, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00154-7 · Cited by 3
Yu, L., & Ren, S. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0324 · Cited by 1
Technological Risk Attitudes in Science Policy
Rozell, D. J. (2020) · Ubiquity Press eBooks · doi:10.5334/bci.d · Cited by 2
“Gene therapy”: ethical and regulatory issues
Pola, S., & Padi, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91376-8.00009-4 · Cited by 1
Genome Editing and Pathological Cardiac Hypertrophy
Kato, T. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-5642-3_6 · Cited by 1
Applications and challenges for CRISPR/Cas9-mediated gene editing
Zhiyang, G. (2022) · AIP conference proceedings · doi:10.1063/5.0115407 · Cited by 1
Human Genome Editing: Managing Technological Risks through Legal Means
TROITSKAYA, A. A., & Sharlovskiy, K. A. (2024) · Journal of Digital Technologies and Law · doi:10.21202/jdtl.2024.27 · Cited by 1
Al‐Maamari, A., Sultan, M., Ding, S., Wu, S., Zhang, T., Qiao, R., Duan, Y., Chen, N., Wu, D., Liu, G., et al. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102150 · Cited by 2
Self-citationPrecision medicine in the management of cardiac arrhythmias
Wiedmann, F., & Schmidt, C. (2025) · Herz · doi:10.1007/s00059-025-05298-x · Cited by 1
Genome editing of human embryos: to edit or not to edit, that is the question
Chandrasegaran, S., Bullen, C. K., & Carroll, D. (2017) · Journal of Clinical Investigation · doi:10.1172/jci96962 · Cited by 1
“A recent Nature article by Ma et al. provides a proof-of-principle demonstration of genome editing technologies to correct germline mutations, reporting targeted correction of the heterozygous MYBPC3 gene mutation that is responsible for hypertrophic cardiomyopathy in human preimplantation embryos (1).”
InfluentialCRISPR–Cas becoming more human
Baumann, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.167 · Cited by 1
Kaser, D. J., & Franasiak, J. M. (2017) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-1075-3 · Cited by 3
“4%) embryos to be restored to wild type, so they were indistinguishable from unaffected embryos [10].”
BackgroundInfluentialDevelopment of capability for genome‐scale CRISPR‐Cas9 knockout screens in New Zealand
Hunter, F. W., Tsai, P., Kakadia, P. M., Bohlander, S. K., Print, C. G., & Wilson, W. R. (2017) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2017.1400984 · Cited by 1
“The biotechnology revolution from CRISPR-Cas9 gene editing is also in its infancy, but its potential was dramatically signalled by the report in August of this year (Ma et al. 2017) of the successful correction of a deleterious gene in viable human embryos.”
BackgroundHuman Reproduction in the Twenty-First Century
Greely, H. T. (2017) · Journal of Posthuman Studies · doi:10.5325/jpoststud.1.2.0205 · Cited by 1
Frankenstein and the Question of Children’s Rights After Human Germline Genetic Modification
Botting, E. H. (2018) · Springer eBooks · doi:10.1007/978-3-319-89429-4_2 · Cited by 1
Application of Gene-Editing Technologies in Embryos and Their Potential for Gene Therapy
Eguizábal, C., Montserrat, N., & Belmonte, J. C. I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813570-9.00030-9 · Cited by 2
Self-citationA tribute to Professor Jay Bailey: A pioneer in biochemical engineering
Khosla, C., Clark, D. S., & Chen, W. (2018) · AIChE Journal · doi:10.1002/aic.16441 · Cited by 1
Эффективность создания делеции CCR5Ddelta32 методом CRISPR-Cas9 в эмбрионах человека
Кодылева, Т. А., Kirillova, A., Тыщик, Е. А., et al. (2018) · Вестник Российского государственного медицинского университета · doi:10.24075/vrgmu.2018.052 · Cited by 1
Germline Modifications as a Severe Intervention into Human Nature
Primc, N. (2018) · Technikzukünfte, Wissenschaft und Gesellschaft · doi:10.1007/978-3-658-22660-2_7 · Cited by 2
Genomveränderungen–CRISPR/Cas9 als Methode der Wahl oder Qual?
Dimova, E. Y., & Kietzmann, T. (2018) · BIOspektrum · doi:10.1007/s12268-018-0977-7 · Cited by 2
CRISPR-CAS9, BIOSSEGURANÇA E BIOÉTICA Uma Análise Jusfilosófica-Ambiental da Engenharia Genética
Reis, É. V. B., & Naves, B. T. D. O. (2019) · Veredas do Direito Direito Ambiental e Desenvolvimento Sustentável · doi:10.18623/rvd.v16i34.1490 · Cited by 53
Nature beyond control: how expectations should inform decisions about human germline engineering
Parent, B., & Turi, A. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01528-4 · Cited by 2
Prospects for the Use of Genome-Editing Technology to Correct Neurodegenerative Diseases
Stepanichev, M. Y. (2019) · Advances in Gerontology · doi:10.1134/s2079057019020218 · Cited by 1
USE OF GENOME EDITING TECHNOLOGIES: ACHIEVEMENTS AND FURURE PROSPECTS
Мохов, А. А., Чапленко, А. А., & Yavorskiy, A. N. (2019) · Journal Biomed · doi:10.33647/2074-5982-15-2-34-42 · Cited by 1
“А как быть с наследственной глухотой или карликовостью? Люди с подобными признаками часто являются полноценными членами общества и не чувствуют себя нуждающимися в «коррекции» [49].”
The IVF Cycle to Come: Laboratory Innovations
Sakkas, D., & Gardner, D. K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108859486.006 · Cited by 2
Cardiomyopathy: Getting Bigger All the Time - Lessons Learned about Heart Disease from Tropomyosin
Wieczorek, D. F. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95509 · Cited by 3
Role of thermal fluctuations in biological copying mechanisms
Das, M., & Kantz, H. (2021) · Physical review. E · doi:10.1103/physreve.103.032110 · Cited by 2
Functional genomics of psychiatric disease risk using genome engineering
García, M. F., Powell, S. K., LaMarca, E. A., Fernando, M. B., Cohen, S., Fang, G., Akbarian, S., & Brennand, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823577-5.00021-0 · Cited by 2
Single-Cell Technologies for Cancer Therapy
Hu, G., Lee, V. D., Lin, H., Mao, P.-W., Liu, H., Peh, J.-H., & Chen, C. (2021) · Springer eBooks · doi:10.1007/978-981-10-8953-4_10 · Cited by 1
Genetics of HCM and Role of Genetic Testing
Semsarian, C., & Ingles, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-92423-6_6 · Cited by 1
Naturwissenschaftliche Einführung
Deuring, S. (2019) · Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim · doi:10.1007/978-3-662-59028-7_2 · Cited by 1
Reprogenetic Technologies and the Valuing of the Biogenetic Family
de Melo‐Martín, I. (2022) · The Muslim World · doi:10.1111/muwo.12444 · Cited by 1
Chakraborty, S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/252296 · Cited by 1
“The getorf program from the EMBOSS suite [13] was used to obtain the ORFs (SI ORFS.”
MethodEfficient Immune Cell Genome Engineering with Improved CRISPR Editing ToolsPreprint
Chan, W., Gottschalk, R. A., Yao, Y., Pomerantz, J. L., & Germain, R. N. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.13.947002 · Cited by 1
“Many reported HDR applications relevant to immune cell manipulation 85 involve targeting embryos (24) or newborn mice (25), not mature immune T cells.”
BackgroundFast but not furious: a streamlined selection method for genome edited cellsPreprint
Ramachandran, H., Martins, S., Kontarakis, Z., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.22.427783 · Cited by 1
Estudio secuencial de la invasion de la mucosa del colon por entamoeba histolytica
Trevino-garcia, N., & Cruz-lavin, E. (1980) · Cited by 1
Rozell, D. J. (2020) · Ubiquity Press eBooks · doi:10.5334/bci.c · Cited by 4
Selita, F. (2023) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/avuq4 · Cited by 1
Foreword for special issue splicing 2016
Capelo, J. L., Santos, H. M., Lodeiro, C., et al. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.08.008
Rewriting the genome in human embryos
Byrne, L. C. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aao4215
Torrance, A. W. (2017) · The Hastings Center Report · doi:10.1002/hast.762 · Cited by 1
The Oncoming Challenge of Homo Superior
Schwartz, S. A. (2017) · EXPLORE · doi:10.1016/j.explore.2017.09.004 · Cited by 1
Gene Editing Nuclear and Mitochondrial DNA
Eguizábal, C., Montserrat, N., & Belmonte, J. C. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64914-0
Self-citationEtiske utfordringer med nyere reproduksjonsteknologi
Hofmann, B. (2017) · Etikk i praksis - Nordic Journal of Applied Ethics · doi:10.5324/eip.v11i2.2247
Renaissance, reinvention, or rhetoric: mitochondria in reproductive medicine 2017
Albertini, D. F. (2017) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-1090-4
“Recalling the milestones from 2017 could focus on any number of topics in reproductivemedicine, ranging from gametes to stem cells to the two-headed scepter of gene editing for curative [2] or basic science explorations [3], and onto variations on the gene-editing theme that may already signal safety and effectiveness…”
BackgroundLiu, Y., Saunders, T. L., Sisson, T. H., Blackburn, R. A., Ginsberg, D. S., & Day, D. E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/254805 · Cited by 1
“CRISPR technology has the potential to correct genetic disorders in patient cells or human embryos and provide new therapies and cures for devastating diseases [1].”
BackgroundGene drive pioneer Kevin Esvelt tries to make science less secret
Eaves, E. (2018) · Bulletin of the Atomic Scientists · doi:10.1080/00963402.2018.1436813
The Intelligent Genome: How Epigenetics Mediates Adaptation
Legato, M. J. (2017) · Gender and the Genome · doi:10.1089/gg.2017.29005.mjl
“Most recently, molecular biologists removed a defective gene from a human embryo that if allowed to fully develop, presumably would live free of hypertrophic cardiomyopathy.(3) So, despite environmental turmoil, we continue to work at answering some of the most critical questions humans have ever asked.”
BackgroundAchievements in 2017, Promises of 2018
Verma, I. C. (2018) · Journal of Fetal Medicine · doi:10.1007/s40556-018-0164-4
On the confluence of reproductive and regenerative medicines
Albertini, D. F. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1177-6
The year 2017 in cardiology: heart failure
Lund, L. H., Køber, L., Swedberg, K. B., & Ruschitzka, F. T. (2018) · Cardiologia Croatica · doi:10.15836/ccar2018.154
Familiäre Kardiomyopathien – von der Phänomenologie zur zielgerichteten Therapie
Amr, A., Katus, H. A., & Meder, B. (2018) · Aktuelle Kardiologie · doi:10.1055/a-0632-4497
“[65] Ma H, Marti-Gutierrez N, Park SW et al.”
BackgroundDid CRISPR really fix a genetic mutation in these human embryos?
Callaway, E. (2018) · Nature · doi:10.1038/d41586-018-05915-2
Prospects for Cure in Wilson Disease
Camarata, M. A., To, U. K., & Schilsky, M. L. (2018) · OBM Genetics · doi:10.21926/obm.genet.1803030
Novel pharmacological approaches for paediatric hypertrophic cardiomyopathy
Coppini, R., Ferrantini, C., & Cerbai, E. (2018) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2018.08.010 · Cited by 1
Embryo as a Patient: New Era Opened
Tesařík, J. (2017) · Journal of Gynecology and Womens Health · doi:10.19080/jgwh.2017.07.555720 · Cited by 1
“Modifications of the CRISPR/Cas-based gene editing technique, enabling a higher precision on the edited genes and limiting undesirable side-effects, have been reported later in 2017 [12,13].”
MethodGravelle, R. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.09.014
Genome Editing Technologies: From Bench Side to Bedside
Tuncay, F. Y., & Dinçer, P. (2018) · Acta Medica · doi:10.32552/2018.actamedica.282 · Cited by 1
“[93] Ma H, Marti-Gutierrez N, Park SW, et al.”
ResultDanowitz, A. M., & Ehret, V. M. (2018) · International Journal of Ethics Education · doi:10.1007/s40889-018-0066-2
Gene Therapy and Genomic Application in Heart Disease
Zhu, F., & Huang, K. (2018) · Translational bioinformatics · doi:10.1007/978-981-13-1429-2_13
Precision in Personalized Prediction-Based Medicine
Kyrochristos, I. D., Ziogas, D. E., & Roukos, D. H. (2018) · Personalized Medicine · doi:10.2217/pme-2018-0079
Who? What? How? Why? If You Don’t Ask You’ll Never Know …
Dabrock, P. (2018) · Technikzukünfte, Wissenschaft und Gesellschaft · doi:10.1007/978-3-658-22660-2_11 · Cited by 1
ARRIGE: Toward a Responsible Use of Genome Editing
Hirsch, F., & Montoliu, L. (2018) · Emerald Group Publishing Limited eBooks · doi:10.1108/s2398-601820180000004008
Genome Editing for Cardiovascular Diseases—A Brief Review for Cardiologists
Hagiwara, N. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.12.003
The Lumbering Crawl Toward Human Germline Editing
Adashi, E. Y., & Cohen, I. G. (2018) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110518822002
El hombre y sus 1001 laberintos genómicos: historia universal de una infamia
Kauffman, M. A. (2019) · Neurología Argentina · doi:10.1016/j.neuarg.2019.01.003
Bondar, T., Carmona, J. A. D. D., Gao, K., Benedetti, B. L., Basson, M., Levinson, R. S., Stower, H., & Farrell, A. (2017) · Nature Medicine · doi:10.1038/nm1217-1387
Schleidgen, S., & Sgodda, S. (2019) · Ethik in der Medizin · doi:10.1007/s00481-019-00530-9 · Cited by 2
Delivery Methods for Treatment of Genetic Disorders
Gupta, K., & Selden, N. R. W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813997-4.00022-0
Assisted Reproductive Technology in Perimenopausal Women
de Guevara, N. M. L., & Guirao, M. A. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_1
International Biomedical Laws in the Field of Genetic Interventions
Lau, P. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-22308-3_5
Fonseca, L. A. B. V. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2019.tde-01082019-082133
Kiewitt-Straßburg, S. (2019) · Zeitschrift für Ethik und Moralphilosophie · doi:10.1007/s42048-019-00043-6
Gene Therapy: Principles and Clinical Potential
Buckley, S. M. K., & David, A. L. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108564434.053
“Genethics” and Public Health Genomics
Niemiec, E., & Howard, H. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813695-9.00013-3
Reproductive medicine involving genome editing
Ishii, T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819178-1.00041-1 · Cited by 2
El Derecho ante la técnica de edición genética CRISPR
Krenz, R. C. (2019) · Acta bioethica · doi:10.4067/s1726-569x2019000200187
Metadata
- Authors
- Ma, H., Marti-Gutierrez, N., Park, S.-W., Wu, J., Lee, Y., Suzuki, K., Koski, A., Ji, D., Hayama, T., Ahmed, R., Darby, H., Van Dyken, C., Li, Y., Kang, E., Park, A.-R., Kim, D., Kim, S.-T., Gong, J., Gu, Y., Xu, X., Battaglia, D., Krieg, S. A., Lee, D. M., Wu, D. H., Wolf, D. P., Heitner, S. B., Belmonte, J. C. I., Amato, P., Kim, J.-S., Kaul, S., & Mitalipov, S.
- Affiliations
- Oregon Health & Science University (US)
- Institute for Basic Science (KR)
- Salk Institute for Biological Studies (US)
- Seoul National University (KR)
- BGI Group (China) (CN)
- Corresponding author
- Amato, Paula
- Kim, Jin-Soo
- Kaul, Sanjiv
- Mitalipov, Shoukhrat
- ORCID
- Venue
- Nature
- Published
- 2017-08
- Volume
- 548
- Issue
- 7668
- Pages
- 413-419
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2740810575
- Cited by
- 992
- References
- 48
- Citations by year
- 2026: 22 · 2025: 50 · 2024: 47 · 2023: 93 · 2022: 75 · 2021: 107 · 2020: 135 · 2019: 155 · 2018: 217 · 2017: 88
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2017-10-02)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- Oregon Health and Science University
- Leona M. and Harry B. Helmsley Charitable Trust
- Consorzio Interuniversitario Biotecnologie
- Moxie Foundation
- Government of Jiangxi Province
- Institute for Basic Science (IBSR021-D1, R021-D1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- germline editing, CRISPR/Cas9, MYBPC3 mutation, hypertrophic cardiomyopathy, preimplantation embryo, homology-directed repair, mosaicism, DNA double-strand break repair, cell cycle timing, preimplantation genetic diagnosis, off-target mutations
- MeSH terms
- Gene Editing, Myosin Binding Protein C, Adult, Alleles, Blastocyst, Carrier Proteins, Cell Division, Embryo, Mammalian, Genetic Complementation Test, Heterozygote, Homozygote, Humans, Male, Mosaicism, Mutation, Templates, Genetic, Zygote, S Phase, Gene Targeting, DNA Breaks, Double-Stranded, Recombinational DNA Repair, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.